Machine Learning-based Longitudinal Study of Post-ICU Syndrome Development Trajectory in Critically Ill Patients and Construction of Clinical Early Warning Models: a Research Protocol for Longitudinal Study
NCT ID: NCT06427265
Last Updated: 2025-05-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
840 participants
OBSERVATIONAL
2023-12-01
2026-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Machine Learning Predictive Models for Sepsis Risk in ICU Patients With Intracerebral Hemorrhage
NCT06326385
To Construct a Prognosis Prediction Model for ECMO Patients Based on Machine Learning Algorithms
NCT06654388
Prognostic Modelling for Prediction of Mortality and Functional Disability in Critically-ill Elderly Patients
NCT06163976
Application of Large Language Models Techniques to Post-ICU Syndrome Management in Critically Ill Patients: A Fully Longitudinal Mixed Study
NCT07141420
Intensive Care Unit Risk Score
NCT04661735
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age ≥18 years old;
* Conscious when leaving ICU, communicating with investigators without barriers;
* Informed consent. Family members:
* One family member ≥18 years of age was selected for each patient;
* Assume the main role of caring for patients and medical decision-making;
* No history of mental illness or other serious organic diseases;
* Informed consent and voluntary participation in this study.
Exclusion Criteria
* Transferred to another ICU;
* Cognitive impairment existed before ICU admission (BDRS \> 4 points);
* Severe hearing impairment, dysarthria, etc., which cannot be followed up;
* Unable to complete the questionnaire survey due to serious illness.
Family members:
* Family members refuse to participate in the study due to their own reasons;
* Severe hearing and language impairment, unable to cooperate with researchers.
18 Years
100 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chinese nursing association
UNKNOWN
The Affiliated Hospital Of Guizhou Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Li Yao
Role: STUDY_CHAIR
Affiliated Hospital of Guizhou Medical University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Affiliated Hospital of Guizhou Medical University
Guiyang, Guizhou, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
No. ZHKYQ202316
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
No. Gyfynsfc[2023]35
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
ZHKYQ202316
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.